BlackRock »

Gt Biopharma shares owned by BlackRock

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-03-31 $45k 10k 4.43

More positions owned by BlackRock

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)

View all positions for BlackRock

Top funds holding Gt Biopharma

DekaBank Deutsche Girozentrale
Vanguard Group
Bank Of Montreal
Geode Capital Management
BlackRock
Wells Fargo & Company
Tower Research Capital
UBS Group
Morgan Stanley
FMR
Advisor Group Holdings
Bank of America Corporation
Blue Bell Private Wealth Management
Royal Bank of Canada
Bnp Paribas Arbitrage, Snc

View all funds holding Gt Biopharma